442. THERAPEUTIC POTENTIAL OF BRAIN-PENETRATING NANOPARTICLES CONTAINING A SELECTIVE VIP RECEPTOR 2 (VIPR2) ANTAGONIST PEPTIDE FOR SCHIZOPHRENIAPublished on 2025-08-184 months ago